BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37410084)

  • 1. Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer.
    Mukherjee A; Ye Y; Wiener HW; Kuniholm MH; Minkoff H; Michel K; Palefsky J; D'Souza G; Rahangdale L; Butler KR; Kempf MC; Sudenga SL; Aouizerat BE; Ojesina AI; Shrestha S
    Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1190-1197. PubMed ID: 37410084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer.
    Safaeian M; Hildesheim A; Gonzalez P; Yu K; Porras C; Li Q; Rodriguez AC; Sherman ME; Schiffman M; Wacholder S; Burk R; Herrero R; Burdette L; Chanock SJ; Wang SS
    PLoS One; 2012; 7(4):e33619. PubMed ID: 22496757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California.
    Castle PE; Shaber R; LaMere BJ; Kinney W; Fetterma B; Poitras N; Lorey T; Schiffman M; Dunne A; Ostolaza JM; McKinney S; Burk RD
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):946-53. PubMed ID: 21415357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Significance of Human Papillomavirus Receptors Related Genetic Variants in Cervical Cancer Screening.
    Xie H; Wei M; Yao L; Liu Y; Xie X; Li X
    Microbiol Spectr; 2023 Aug; 11(4):e0511722. PubMed ID: 37358427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study.
    Valls J; Baena A; Venegas G; Celis M; González M; Sosa C; Santin JL; Ortega M; Soilán A; Turcios E; Figueroa J; Rodríguez de la Peña M; Figueredo A; Beracochea AV; Pérez N; Martínez-Better J; Lora O; Jiménez JY; Giménez D; Fleider L; Salgado Y; Martínez S; Bellido-Fuentes Y; Flores B; Tatti S; Villagra V; Cruz-Valdez A; Terán C; Sánchez GI; Rodríguez G; Picconi MA; Ferrera A; Mendoza L; Calderón A; Murillo R; Wiesner C; Broutet N; Luciani S; Pérez C; Darragh TM; Jerónimo J; Herrero R; Almonte M;
    Lancet Glob Health; 2023 Mar; 11(3):e350-e360. PubMed ID: 36796982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical Cancer Screening: A Review.
    Perkins RB; Wentzensen N; Guido RS; Schiffman M
    JAMA; 2023 Aug; 330(6):547-558. PubMed ID: 37552298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.
    Castle PE; Solomon D; Schiffman M; Wheeler CM
    J Natl Cancer Inst; 2005 Jul; 97(14):1066-71. PubMed ID: 16030304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
    BMC Cancer; 2022 Jan; 22(1):42. PubMed ID: 34991494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants in human papillomavirus receptor and associated genes are associated with type-specific HPV infection and lesion progression of the cervix.
    Zou J; Cao Z; Zhang J; Chen T; Yang S; Huang Y; Hong D; Li Y; Chen X; Wang X; Cheng X; Lu W; Xie X
    Oncotarget; 2016 Jun; 7(26):40135-40147. PubMed ID: 27223085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3.
    Castle PE; Schiffman M; Wheeler CM; Wentzensen N; Gravitt PE
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1675-81. PubMed ID: 20615885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study.
    Castle PE; Gravitt PE; Solomon D; Wheeler CM; Schiffman M
    J Clin Microbiol; 2008 Jan; 46(1):109-17. PubMed ID: 17989194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women.
    La Ruche G; You B; Mensah-Ado I; Bergeron C; Montcho C; Ramon R; Touré-Coulibaly K; Welffens-Ekra C; Dabis F; Orth G
    Int J Cancer; 1998 May; 76(4):480-6. PubMed ID: 9590121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
    [No Abstract]   [Full Text] [Related]  

  • 15. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification for cervical precancer and cancer by DH3-HPV partial genotyping and cytology in women attending cervical screening: A retrospective cohort study.
    Fu Y; Li Y; Li X; Wang X; Lü W
    J Med Virol; 2023 Feb; 95(2):e28482. PubMed ID: 36609841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precancer of the human cervix.
    Pontén J; Guo Z
    Cancer Surv; 1998; 32():201-29. PubMed ID: 10489629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of HPV in the Prediction of Persistence/Recurrence After Treatment for Cervical Precancer.
    Kulkarni A; Covens A; Durand N; Ghorab Z; Gien LT; Osborne R; Vicus D; Kupets R
    J Obstet Gynaecol Can; 2023 Oct; 45(10):102171. PubMed ID: 37343621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.
    Chatterjee K; Dandara C; Hoffman M; Williamson AL
    BMC Cancer; 2010 Jun; 10():278. PubMed ID: 20537184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential impact of combined high- and low-risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2.
    Okadome M; Saito T; Tanaka H; Nogawa T; Furuta R; Watanabe K; Kita T; Yamamoto K; Mikami M; Takizawa K;
    J Obstet Gynaecol Res; 2014 Feb; 40(2):561-9. PubMed ID: 24147758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.